Skip to main content
SpringerLink
Log in

The effect of pentoxifylline on penile cavernosal tissues in ischemic priapism-induced rat model

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Introduction

Priapism is defined as persisting (>4 h), painful and abnormal tumescence that can occur without sexual stimulation. Three subtypes priapisms are seen—the non-ischemic priapism, intermittent and the ischemic priapism. In ischemic priapism, there is an abnormality in the veno-occlusive mechanism, resulting in venous stasis and accumulation of deoxygenated blood within the penile cavernosal tissue. Cavernosal tissue necrosis develops after extended period of ischemia and is eventually replaced by fibrotic tissue. It may results in erectile dysfunction if not treated promptly. Although, standard treatment of the ischemic priapism is penile aspiration and intracavernosal alpha-adrenergic agents, new oral agents have been investigated to reduce the cavernosal damage. In this study, the effect of different doses of pentoxifylline on cavernosal tissues was evaluated.

Materials and methods

Thirty-six male Wistar albino rats, age 5.5–6 months and weighing 250–300 g, were used in this study. The rats were randomly divided into five groups. In Group 1 (n = 7), the control group, only penectomy was performed. In Group 2 (n = 8), after 1 h of ischemic priapism, penectomy was performed. Group 3 (n = 7) received daily a 10 mg oral pentoxifylline for 4 weeks after 1 h of ischemic priapism, group 4 (n = 7) received a daily 30 mg oral pentoxifylline for 4 weeks after 1 h of ischemic priapism, and group 5 (n = 7) received a daily 100 mg oral pentoxifylline for 4 weeks after 1 h of ischemic priapism. At the completion of a 4-week period, penile tissues were obtained. Before penile tissues were obtained, intracavernosal pressures measured with electrical field stimulation and smooth muscle collagen ratio were evaluated pathologically.

Results

Electrical field stimulation-induced intracavernosal relaxation decreased in group 2 compared with group 1 (p < 0.05). Electrical field stimulation-induced relaxation enhanced in the group 3, 4 and 5 compared to group 2 (p < 0.05). In group 2, the collagen density was significantly higher than group 1. Administration of pentoxifylline reduced the collagen density caused by ischemic priapism in groups 3, 4 and 5 compared with group 2.

Conclusion

The results of the present study showed that ischemic priapism caused damage in the penile tissues of rats, and treatment with pentoxifylline reduced the harmful effects of ischemic priapism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Papadopoulos I, Kelâmi A (1988) Priapus and priapism. From mythology to medicine. Urology 32:385–386

    Article  PubMed  CAS  Google Scholar 

  2. Lue TF (1998) Physiology of penile erection and pathophysiology of erectile dysfunction and priapism. In: Walsh P, Retik AB, Vaughan ED, Wein AJ (eds) Campbell’s Urology, vol 3, 7th edn. Saunders Company, Philadelphia, pp 1157–1174

    Google Scholar 

  3. Minardi D, Milanese G, Galosi AB, Donatelli G, Muzzonigro G (2004) Persistent priapism and histological modifications of the erectile tissue. Two case reports. Arch Ital Urol Androl 76:97–99

    PubMed  Google Scholar 

  4. Zheng DC, Yao HJ, Zhang K, Xu MX, Chen Q, Chen YB, Cai ZK, Lu MJ, Wang Z (2013) Unsatisfactory outcomes of prolonged ischemic priapism without early surgical shunts: our clinical experience and a review of the literature. Asian J Androl 15:75–78

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Tay YK, Spernat D, Rzetelski-West K, Appu S, Love C (2012) Acute management of priapism in men. BJU Int 109(Suppl 3):15–21

    Article  PubMed  Google Scholar 

  6. Merkus D, Visser M, Houweling B, Zhou Z, Nelson J, Duncker DJ (2013) Phosphodiesterase 5 inhibition-induced coronary vasodilation is reduced after myocardial infarction. Am J Physiol Heart Circ Physiol 304:1370–1381

    Article  Google Scholar 

  7. Pyriochou A, Zhou Z, Koika V, Petrou C, Cordopatis P, Sessa WC, Papapetropoulos A (2007) The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway. J Cell Physiol 211:197–204

    Article  PubMed  CAS  Google Scholar 

  8. Salhiyyah K, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA. Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev. Jan 18, 2012;1:CD005262. doi:10.1002/14651858.CD005262.pub2

  9. Seifi B, Kadkhodaee M, Delavari F, Mikaeili S, Shams S, Ostad SN (2012) Pretreatment with pentoxifylline and N-acetylcysteine in liver ischemia reperfusion-induced renal injury. Ren Fail 34:610–615

    Article  PubMed  CAS  Google Scholar 

  10. Bruno Rde B, Marques TF, Batista TM, Lima JC, de Arruda KG, Lima PF, Santos Nda S, Cunha GM, Vitor HV, Viana GS (2009) Pentoxifylline treatment improves neurological and neurochemical deficits in rats subjected to transient brain ischemia. Brain Res 1260:55–64

    Article  PubMed  Google Scholar 

  11. Sanli O, Armagan A, Kandirali E, Ozerman B, Ahmedov I, Solakoglu S, Nurten A, Tunç M, Uysal V, Kadioglu A (2004) TGF-beta1 neutralizing antibodies decrease the fibrotic effects of ischemic priapism. Int J Impot Res 16:492–497

    Article  PubMed  CAS  Google Scholar 

  12. Roghmann F, Becker A, Sammon JD, Ouerghi M, Sun M, Sukumar S, Djahangirian O, Zorn KC, Ghani KR, Gandaglia G, Menon M, Karakiewicz P, Noldus J, Trinh QD (2013) Incidence of priapism in emergency departments in the United States. J Urol 190:1275–1280

    Article  PubMed  Google Scholar 

  13. Kadioglu A, Sanli O, Celtik M, Cakan M, Taskapu H, Akman T (2006) Practical management of patients with priapism. EAU-EBU Updat Ser 4:150–160

    Article  Google Scholar 

  14. Coombs PG, Heck M, Guhring P, Narus J, Mulhall JP (2012) A review of outcomes of an intracavernosal injection therapy programme. BJU Int 110:1787–1791

    Article  PubMed  CAS  Google Scholar 

  15. Burnett AL, Bivalacqua TJ (2007) Priapism: current principles and practice. Urol Clin N Am 34:631–642

    Article  Google Scholar 

  16. Sadeghi-Nejad H, Seftel AD (2002) The etiology, diagnosis, and treatment of priapism: review of the American Foundation for Urologic Disease Consensus Panel Report. Curr Urol Rep 3:492–498

    Article  PubMed  Google Scholar 

  17. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R (2010) Priapism: pathogenesis, epidemiology, and management. J Sex Med 7:476–500

    Article  PubMed  Google Scholar 

  18. El-Bahnasawy MS, Dawood A, Farouk A (2002) Low-flow priapism: risk factors for erectile dysfunction. BJU Int 89:285–290

    Article  PubMed  CAS  Google Scholar 

  19. Kovac JR, Mak SK, Garcia MM, Lue TF (2013) A pathophysiology-based approach to the management of early priapism. Asian J Androl 15:20–26

    Article  PubMed  PubMed Central  Google Scholar 

  20. Gottsch HP, Berger RE, Yang CC (2012) Priapism: comorbid factors and treatment outcomes in a contemporary series. Adv Urol 2012:672624

    Article  PubMed  PubMed Central  Google Scholar 

  21. Hinman F (1914) Priapism: report of cases and a clinical study of the literature with reference to its pathogenesis and surgical treatment. Ann Surg 60:689–716

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N (2002) Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 136:515–522

    Article  PubMed  CAS  Google Scholar 

  23. Fries R, Shariat K, Von WH, Bohm M (2005) Sildenafil in the treatment of Raynaud’s phenomenon resistant to vasodilatory therapy. Circulation 112:2980–2985

    PubMed  CAS  Google Scholar 

  24. Sharma R (2007) Novel phosphodiesterase-5 inhibitors: current indications and future directions. Indian J Med Sci 61:667–679

    Article  PubMed  Google Scholar 

  25. Liu Y, Shakur Y, Kambayashi J (2011) Phosphodiesterases as targets for intermittent claudication. Handb Exp Pharmacol 204:211–236

    Article  PubMed  CAS  Google Scholar 

  26. Porter JM, Cutler BS, Lee BY, Reich T, Reichle FA, Scogin JT, Strandness DE (1982) Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J 104:66–72

    Article  PubMed  CAS  Google Scholar 

  27. Strano A, Davi G, Avellone G, Novo S, Pinto A (1984) Double blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology 35:459–466

    Article  PubMed  CAS  Google Scholar 

  28. Ladurner G, Kalvach P, Moessler H (2005) Cerebrolysin study group. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. J Neural Transm 112:415–428

    Article  PubMed  CAS  Google Scholar 

  29. Toda K, Kumagai N, Kaneko F, Tsunematsu S, Tsuchimoto K, Saito H, Hibi T (2009) Pentoxifylline prevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production. J Gastroenterol Hepatol 24:860–865

    Article  PubMed  CAS  Google Scholar 

  30. Ng YY, Chen YM, Tsai TJ, Lan XR, Yang WC, Lan HY (2009) Pentoxifylline inhibits transforming growth factor-beta signaling and renal fibrosis in experimental crescentic glomerulonephritis in rats. Am J Nephrol 29:43–53

    Article  PubMed  CAS  Google Scholar 

  31. Hung KY, Huang JW, Chiang CK, Tsai TJ (2008) Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies. Nephrol Dial Transpl 23:3831–3840

    Article  CAS  Google Scholar 

  32. Flechner L, Breyer BN, Eisenberg ML, Lue TF (2011) Pentoxifylline treatment and penile calcifications in men with Peyronie’s disease. Asian J Androl 13:322–325

    Article  PubMed  PubMed Central  Google Scholar 

  33. Lin G, Shindel AW, Banie L (2010) Pentoxifylline attenuates transforming growth factor-beta1-stimulated elastogenesis in human tunica albuginea-derived fibroblasts part 2: interference in a TGF-beta1/Smad-dependent mechanism and downregulation of AAT1. J Sex Med 7:1787–1797

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  34. Albersen M, Fandel TM, Zhang H, Banie L, Lin G, De Ridder D, Lin CS, Lue TF (2011) Pentoxifylline promotes recovery of erectile function in a rat model of postprostatectomy erectile dysfunction. Eur Urol 59:286–296

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  35. Nasiri-Toosi Z, Dashti-Khavidaki S, Khalili H, Lessan-Pezeshki M (2013) A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity. Eur J Clin Pharmacol 69:1057–1073

    Article  PubMed  CAS  Google Scholar 

  36. Abo-Salem OM (2013) Uroprotective effect of pentoxifylline in cyclophosphamide-induced hemorrhagic cystitis in rats. J Biochem Mol Toxicol 27:343–350

    Article  PubMed  CAS  Google Scholar 

  37. Archer SL, Roudebush WE (2013) Enhancement of sperm motility using pentoxifylline and platelet-activating factor. Methods Mol Biol 927:241–245

    Article  PubMed  CAS  Google Scholar 

  38. Savaş C, Dindar H, Aras T, Yücesan S (2002) Pentoxifylline improves blood flow to both testes in testicular torsion. Int Urol Nephrol 33:81–85

    Article  PubMed  Google Scholar 

  39. Tzeng YS, Tang SH, Meng E, Lin TF, Sun GH (2004) Ischemic glans penis after circumcision. Asian J Androl 6:161–163

    PubMed  Google Scholar 

  40. Lin SL, Chen RH, Chen YM, Chiang WC, Lai CF, Wu KD, Tsai TJ (2005) Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. J Am Soc Nephrol 16:2702–2713

    Article  PubMed  CAS  Google Scholar 

  41. Evliyaoğlu Y, Kayrin L, Kaya B (1997) Effect of pentoxifylline on veno-occlusive priapism-induced corporeal tissue lipid peroxidation in a rat model. Urol Res 25:143–147

    Article  PubMed  Google Scholar 

  42. Rajfer J, Gore JL, Kaufman J, Gonzalez-Cadavid N (2006) Case report: avoidance of palpable corporal fibrosis due to priapism with upregulators of nitric oxide. J Sex Med 3:173–176

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

No conflict of interest was declared by the authors.

Author information

Authors and Affiliations

  1. Department of Urology, Gaziosmanpasa University, Tokat, Turkey

    Fikret Erdemir, Fatih Firat, Dogan Atilgan, Bekir Suha Parlaktas & Yusuf Gencten

  2. Department of Pathology, Gaziosmanpasa University, Tokat, Turkey

    Fatma Markoc

  3. Department of Biostatistics, Gaziosmanpasa University, Tokat, Turkey

    Yunus Emre Kuyucu

  4. Bahçelievler M. Ülkü Cad. 4. Sok. No:16 D:1/2 60100, Merkez, Tokat, Turkey

    Fikret Erdemir

Authors
  1. Fikret Erdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fatih Firat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatma Markoc
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dogan Atilgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bekir Suha Parlaktas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yunus Emre Kuyucu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yusuf Gencten
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fikret Erdemir.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erdemir, F., Firat, F., Markoc, F. et al. The effect of pentoxifylline on penile cavernosal tissues in ischemic priapism-induced rat model. Int Urol Nephrol 46, 1961–1967 (2014). https://doi.org/10.1007/s11255-014-0769-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0769-z

Keywords

Search

Navigation